Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Director comp.
CC transcript
|
|
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPDI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/08/2021 |
3/A
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3/A on Science 37 Holdings, Inc. |
| 10/18/2021 |
3
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3 on Science 37 Holdings, Inc. |
| 08/01/2018 |
4
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Converted 442,819 shares
@ $0
Converted 3,420,516 preferred shares
@ $0 |
|
| 07/25/2018 |
3
| PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (10% Owner) has filed a Form 3 on Liquidia Technologies Inc |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/06/2011 |
4
| Hill Raymond H (CEO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 30,000 restricted stock units
@ $0
Disposed/sold 150,000 options to buy
@ $28.54, valued at
$4.3M
|
|
| 12/06/2011 |
4
| SNYDERMAN RALPH (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 1,139 shares
@ $33.25, valued at
$37.9k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
|
|
| 12/06/2011 |
4
| Sharbaugh William J (COO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Unknown transaction of 324 shares
@ $24.98, valued at
$8.1k
Disposed/sold 13,906 shares
@ $33.25, valued at
$462.4k
Disposed/sold 45,000 options to buy
@ $27.27, valued at
$1.2M
Disposed/sold 30,000 options to buy
@ $26.64, valued at
$799.2k
Disposed/sold 62,104 options to buy
@ $20.45, valued at
$1.3M
Disposed/sold 62,104 options to buy
@ $25.74, valued at
$1.6M
Disposed/sold 27,947 options to buy
@ $19.94, valued at
$557.3k
Disposed/sold 27,947 options to buy
@ $37.69, valued at
$1.1M
Disposed/sold 62,104 options to buy
@ $43.26, valued at
$2.7M
Disposed/sold 77,630 options to buy
@ $35.26, valued at
$2.7M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| Richardson William W (Sr. VP Global Bus. Development) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Unknown transaction of 90 shares
@ $24.98, valued at
$2.2k
Disposed/sold 1,144 shares
@ $33.25, valued at
$38k
Disposed/sold 15,000 options to buy
@ $27.27, valued at
$409.1k
Disposed/sold 6,250 options to buy
@ $26.64, valued at
$166.5k
Disposed/sold 12,939 options to buy
@ $20.45, valued at
$264.6k
Disposed/sold 12,939 options to buy
@ $25.74, valued at
$333k
Disposed/sold 7,246 options to buy
@ $19.94, valued at
$144.5k
Disposed/sold 7,246 options to buy
@ $37.69, valued at
$273.1k
Disposed/sold 15,526 options to buy
@ $43.26, valued at
$671.7k
Disposed/sold 23,289 options to buy
@ $32.47, valued at
$756.2k
Disposed/sold 51,753 options to buy
@ $27.84, valued at
$1.4M
|
|
| 12/06/2011 |
4
| MARIO ERNEST (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 214,750 shares
@ $33.25, valued at
$7.1M
Disposed/sold 193,069 shares
@ $33.25, valued at
$6.4M
Disposed/sold 58,244 shares
@ $33.25, valued at
$1.9M
Disposed/sold 6,000 shares
@ $33.25, valued at
$199.5k
Disposed/sold 9,090 options to buy
@ $24.26, valued at
$220.5k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
Disposed/sold 10,496 options to buy
@ $24.52, valued at
$257.4k
Disposed/sold 14,053 options to buy
@ $19.19, valued at
$269.7k
Disposed/sold 5,650 options to buy
@ $22.98, valued at
$129.8k
Disposed/sold 4,113 options to buy
@ $34.18, valued at
$140.6k
Disposed/sold 6,341 options to buy
@ $32.67, valued at
$207.2k
|
|
| 12/06/2011 |
4
| MAGNUSON TERRY (10% Owner) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 17,633 shares
@ $33.25, valued at
$586.3k
Disposed/sold 9,090 options to buy
@ $24.26, valued at
$220.5k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
Disposed/sold 10,496 options to buy
@ $24.52, valued at
$257.4k
Disposed/sold 14,053 options to buy
@ $19.19, valued at
$269.7k
Disposed/sold 6,485 options to buy
@ $41.32, valued at
$268k
Disposed/sold 6,341 options to buy
@ $32.67, valued at
$207.2k
Disposed/sold 12,421 options to buy
@ $12.37, valued at
$153.6k
Disposed/sold 16,561 options to buy
@ $13.12, valued at
$217.3k
Disposed/sold 16,561 options to buy
@ $15.28, valued at
$253.1k
Disposed/sold 5,650 options to buy
@ $22.98, valued at
$129.8k
|
|
| 12/06/2011 |
4
| Wilkinson Michael O. (Chief Information Officer) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Unknown transaction of 280 shares
@ $24.98, valued at
$7k
Disposed/sold 2,362 shares
@ $33.25, valued at
$78.5k
Disposed/sold 12,485 options to buy
@ $25.74, valued at
$321.4k
Disposed/sold 21,052 options to buy
@ $20.45, valued at
$430.5k
Disposed/sold 15,000 options to buy
@ $26.64, valued at
$399.6k
Disposed/sold 6,211 options to buy
@ $19.94, valued at
$123.8k
Disposed/sold 18,632 options to buy
@ $37.69, valued at
$702.2k
Disposed/sold 7,763 options to buy
@ $43.26, valued at
$335.8k
Disposed/sold 62,104 options to buy
@ $33.8, valued at
$2.1M
Disposed/sold 10,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 1,139 shares
@ $33.25, valued at
$37.9k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
|
|
| 12/06/2011 |
4
| HARTMAN JUDD (General Counsel) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 6,211 options to buy
@ $19.94, valued at
$123.8k
Disposed/sold 34,503 options to buy
@ $20.45, valued at
$705.6k
Disposed/sold 45,000 options to buy
@ $27.27, valued at
$1.2M
Disposed/sold 25,000 options to buy
@ $26.64, valued at
$666k
Disposed/sold 36,227 options to buy
@ $25.74, valued at
$932.5k
Disposed/sold 18,632 options to buy
@ $37.69, valued at
$702.2k
Disposed/sold 46,630 options to buy
@ $43.26, valued at
$2M
Disposed/sold 41,403 options to buy
@ $33.44, valued at
$1.4M
Disposed/sold 15,526 options to buy
@ $32.47, valued at
$504.1k
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| FRANK FRED (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 72,565 shares
@ $33.25, valued at
$2.4M
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
Disposed/sold 9,090 options to buy
@ $24.26, valued at
$220.5k
Disposed/sold 10,496 options to buy
@ $24.52, valued at
$257.4k
Disposed/sold 14,053 options to buy
@ $19.19, valued at
$269.7k
Disposed/sold 6,485 options to buy
@ $41.32, valued at
$268k
Disposed/sold 6,341 options to buy
@ $32.67, valued at
$207.2k
Disposed/sold 4,113 options to buy
@ $34.18, valued at
$140.6k
Disposed/sold 12,421 options to buy
@ $12.37, valued at
$153.6k
Disposed/sold 16,561 options to buy
@ $13.12, valued at
$217.3k
Disposed/sold 16,561 options to buy
@ $14.55, valued at
$241k
|
|
| 12/06/2011 |
4
| ESHELMAN FREDRIC N (Executive Chairman) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed of 15,000 shares
@ $0
Acquired 15,000 shares
@ $0
Disposed/sold 6,984,741 shares
@ $33.25, valued at
$232.2M
Disposed/sold 394,500 shares
@ $33.25, valued at
$13.1M
Disposed/sold 11,258 shares
@ $33.25, valued at
$374.3k
Disposed/sold 1,685 shares
@ $33.25, valued at
$56k
Disposed/sold 90,000 options to buy
@ $27.27, valued at
$2.5M
Disposed/sold 103,506 options to buy
@ $20.45, valued at
$2.1M
Disposed/sold 103,506 options to buy
@ $25.74, valued at
$2.7M
Disposed/sold 51,753 options to buy
@ $19.94, valued at
$1M
Disposed/sold 103,506 options to buy
@ $43.26, valued at
$4.5M
|
|
| 12/06/2011 |
4
| Dingivan Christine A (EVP/Chief Medical Officer) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 45,000 options to buy
@ $27.27, valued at
$1.2M
Disposed/sold 20,000 options to buy
@ $26.64, valued at
$532.8k
Disposed/sold 41,403 options to buy
@ $20.45, valued at
$846.7k
Disposed/sold 31,052 options to buy
@ $25.74, valued at
$799.3k
Disposed/sold 7,763 options to buy
@ $19.94, valued at
$154.8k
Disposed/sold 7,763 options to buy
@ $37.69, valued at
$292.6k
Disposed/sold 93,156 options to buy
@ $36.65, valued at
$3.4M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| Darazsdi Daniel G (CFO) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Unknown transaction of 323 shares
@ $24.98, valued at
$8.1k
Disposed/sold 13,195 shares
@ $33.25, valued at
$438.7k
Disposed/sold 30,000 options to buy
@ $26.64, valued at
$799.2k
Disposed/sold 45,000 options to buy
@ $27.27, valued at
$1.2M
Disposed/sold 62,104 options to buy
@ $20.45, valued at
$1.3M
Disposed/sold 62,104 options to buy
@ $25.74, valued at
$1.6M
Disposed/sold 23,289 options to buy
@ $19.94, valued at
$464.4k
Disposed/sold 23,289 options to buy
@ $37.69, valued at
$877.8k
Disposed/sold 46,578 options to buy
@ $43.26, valued at
$2M
Disposed/sold 93,156 options to buy
@ $34.15, valued at
$3.2M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| COLVIN PAUL (EVP--Clinical Development) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Unknown transaction of 20 shares
@ $24.98, valued at
$499.6
Disposed/sold 45 shares
@ $33.25, valued at
$1.5k
Disposed/sold 3,753 options to buy
@ $19.94, valued at
$74.8k
Disposed/sold 11,041 options to buy
@ $20.45, valued at
$225.8k
Disposed/sold 30,000 options to buy
@ $27.27, valued at
$818.1k
Disposed/sold 16,000 options to buy
@ $26.64, valued at
$426.2k
Disposed/sold 15,992 options to buy
@ $25.74, valued at
$411.6k
Disposed/sold 11,386 options to buy
@ $37.69, valued at
$429.1k
Disposed/sold 15,526 options to buy
@ $43.26, valued at
$671.7k
Disposed/sold 31,052 options to buy
@ $37.51, valued at
$1.2M
Disposed/sold 10,000 restricted stock units
@ $0 |
|
| 12/06/2011 |
4
| BRYSON VAUGHN D (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 1,139 shares
@ $33.25, valued at
$37.9k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
|
|
| 12/06/2011 |
4
| BONDURANT STUART (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 21,479 shares
@ $33.25, valued at
$714.2k
Disposed/sold 9,095 options to buy
@ $28.52, valued at
$259.4k
Disposed/sold 10,496 options to buy
@ $24.52, valued at
$257.4k
Disposed/sold 14,053 options to buy
@ $19.19, valued at
$269.7k
Disposed/sold 6,485 options to buy
@ $41.32, valued at
$268k
Disposed/sold 6,341 options to buy
@ $32.67, valued at
$207.2k
Disposed/sold 4,113 options to buy
@ $34.18, valued at
$140.6k
Disposed/sold 5,650 options to buy
@ $22.98, valued at
$129.8k
|
|
| 12/06/2011 |
4
| Babiss Lee (Exec. VP--Global Lab Services) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $27.27, valued at
$818.1k
Disposed/sold 15,000 options to buy
@ $26.64, valued at
$399.6k
Disposed/sold 46,578 options to buy
@ $20.45, valued at
$952.5k
Disposed/sold 10,000 restricted stock units
@ $0 |
|
| 12/05/2011 |
8-K
| Quarterly results |
| 12/05/2011 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/15/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/14/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 11/10/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
|
|